XML 22 R3.htm IDEA: XBRL DOCUMENT v3.24.3
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Millions, $ in Millions
12 Months Ended
Sep. 27, 2024
Sep. 29, 2023
Sep. 30, 2022
Income Statement [Abstract]      
Revenues, net $ 811.0 $ 893.4 $ 859.4
Cost of revenues 554.1 603.1 575.9
Gross profit 256.9 290.3 283.5
Operating expenses:      
Research and development 87.0 84.8 77.0
Selling, general and administrative 137.8 128.4 118.3
Total operating expenses 224.8 213.2 195.3
Operating income 32.1 77.1 88.2
Interest income 7.3 3.7 0.4
Interest expense (30.2) (29.3) (39.8)
Other expense, net (4.2) (20.2) (4.3)
Interest and other expense, net (27.1) (45.8) (43.7)
Income before taxes 5.0 31.3 44.5
Income tax expense (benefit) 52.2 (17.4) 13.7
Net (loss) income (47.2) 48.7 30.8
Less: Net income attributable to noncontrolling interests 0.5 0.5 0.5
Net (loss) income attributable to Varex $ (47.7) $ 48.2 $ 30.3
Net (loss) income per common share attributable to Varex      
Basic (in USD per share) $ (1.17) $ 1.20 $ 0.76
Diluted (in USD per share) $ (1.17) $ 1.08 $ 0.73
Weighted average common shares outstanding      
Basic (in shares) 40.8 40.3 39.8
Diluted (in shares) 40.8 50.3 41.6